Danvatirsen
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Danvatirsen, covering 2025-05-06 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC [Phase 2]